These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19567611)

  • 1. Intravenous alpha1-antitrypsin in a child with deficiency and severe lung disease.
    Griese M; Brüggen H
    Eur Respir J; 2009 Jul; 34(1):278-9. PubMed ID: 19567611
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe ulcerative panniculitis caused by alpha 1-antitrypsin deficiency: remission induced and maintained with intravenous alpha 1-antitrypsin.
    Al-Niaimi F; Lyon C
    J Am Acad Dermatol; 2011 Jul; 65(1):227-9. PubMed ID: 21679830
    [No Abstract]   [Full Text] [Related]  

  • 3. [Expert statement for augmentation therapy in patients with alpha-1 antitrypsin deficiency].
    Köhnlein T; Schmidt-Scherzer K; Greulich T; Bals R
    Pneumologie; 2014 Jul; 68(7):492-5. PubMed ID: 25006842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha 1-antitrypsin deficiency and the impact of nursing interventions and treatment with intravenous therapy. An overview.
    Scharnweber K
    J Intraven Nurs; 1999; 22(5):258-64. PubMed ID: 10776189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.
    Stoller JK; Aboussouan LS
    Thorax; 2004 Aug; 59(8):708-12. PubMed ID: 15282394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of biweekly α
    Greulich T; Chlumsky J; Wencker M; Vit O; Fries M; Chung T; Shebl A; Vogelmeier C; Chapman KR; McElvaney NG;
    Eur Respir J; 2018 Nov; 52(5):. PubMed ID: 30237305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha1-antitrypsin deficiency-associated panniculitis: case report and review of treatment options.
    Ortiz PG; Skov BG; Benfeldt E
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):487-90. PubMed ID: 15987301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE).
    McElvaney NG; Burdon J; Holmes M; Glanville A; Wark PA; Thompson PJ; Hernandez P; Chlumsky J; Teschler H; Ficker JH; Seersholm N; Altraja A; Mäkitaro R; Chorostowska-Wynimko J; Sanak M; Stoicescu PI; Piitulainen E; Vit O; Wencker M; Tortorici MA; Fries M; Edelman JM; Chapman KR;
    Lancet Respir Med; 2017 Jan; 5(1):51-60. PubMed ID: 27916480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha 1-antitrypsin deficiency alleles in cystic fibrosis lung disease.
    Frangolias DD; Ruan J; Wilcox PJ; Davidson AG; Wong LT; Berthiaume Y; Hennessey R; Freitag A; Pedder L; Corey M; Sweezey N; Zielenski J; Tullis E; Sandford AJ
    Am J Respir Cell Mol Biol; 2003 Sep; 29(3 Pt 1):390-6. PubMed ID: 12689922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Emphysema in a Child With Alpha-1 Antitrypsin Deficiency: Evaluation of 2 Years of Intravenous Augmentation Therapy.
    Esteves Brandão M; Conde B; Seixas S; Clotilde Silva J; Fernandes A
    Arch Bronconeumol (Engl Ed); 2019 Sep; 55(9):502-504. PubMed ID: 30871819
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
    Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
    Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging drugs for alpha-1-antitrypsin deficiency.
    Stockley RA
    Expert Opin Emerg Drugs; 2010 Dec; 15(4):685-94. PubMed ID: 20716026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key current clinical issues in alpha-1 antitrypsin deficiency.
    Stoller JK
    Respir Care; 2003 Dec; 48(12):1216-21; discussion 1221-4. PubMed ID: 14651762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of augmentation therapy on bronchial inflammation in alpha1-antitrypsin deficiency.
    Stockley RA; Bayley DL; Unsal I; Dowson LJ
    Am J Respir Crit Care Med; 2002 Jun; 165(11):1494-8. PubMed ID: 12045122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled alpha1-antitrypsin administered to treat pneumatocele in autosomal dominant hyperimmunoglobulin E syndrome.
    Karakoc-Aydiner E; Baris S; Keles S; Ozdemir C; Chatila T; Barlan I
    J Investig Allergol Clin Immunol; 2013; 23(5):359-61. PubMed ID: 24260982
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of panniculitis associated with alpha-1-antitrypsin deficiency with alpha-1-protease inhibitor.
    Kjus T; Lützow-Holm C; Christensen OB
    Acta Derm Venereol; 2003; 83(6):462-3. PubMed ID: 14690345
    [No Abstract]   [Full Text] [Related]  

  • 17. A diagnostic dilemma: case study of a 36-year-old female with alpha-1-antitrypsin deficiency.
    Lawrence RA; Clark JP
    W V Med J; 2005; 101(2):73-4. PubMed ID: 16042092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term therapy of alpha 1-antitrypsin-deficiency-associated pulmonary emphysema with human alpha 1-antitrypsin].
    Wencker M; Banik N; Buhl R; Seidel R; Konietzko N
    Pneumologie; 1998 Oct; 52(10):545-52. PubMed ID: 9847632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alpha-1 antitrypsin in chronic pulmonary diseases].
    Chmielewska D; Gutkowska J
    Gruzlica; 1975 May; 43(5):455-60. PubMed ID: 1079781
    [No Abstract]   [Full Text] [Related]  

  • 20. Results of a survey of patients with alpha-1 antitrypsin deficiency.
    Strange C; Stoller JK; Sandhaus RA; Dickson R; Turino G
    Respiration; 2006; 73(2):185-90. PubMed ID: 16141711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.